SHELMITH MAMO: Open Payments
NPI 1194122341 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 12 payments from 5 companies in 2025. Trend: 2023 $231 · 2024 $382 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $590 |
| ABBVIE INC. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $116 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| Janssen Pharmaceuticals, Inc | 1 | $110 |
Products named: COBENFY, VRAYLAR, CAPLYTA, UZEDY, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
